Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation
- PMID: 20308603
- PMCID: PMC2881498
- DOI: 10.1182/blood-2009-10-247973
Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation
Abstract
Familial aggregation of Waldenström macroglobulinemia (WM) and related B-cell disorders (BCDs) suggests a role for genetic factors, but few data address environmental influences. We designed a questionnaire-based study to examine clinical and environmental factors in a cohort of WM families with various patterns of case aggregation. We analyzed data on 103 WM patients and 272 unaffected relatives from 35 multiple-case WM and 46 mixed WM/BCD kindred and 28 nonfamilial (sporadic) WM patients, using logistic regression models with generalized estimating equations to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for association. In this study population, the WM disease process appeared similar among patients regardless of family history. Familial WM patients were more likely than unaffected relatives to report a history of autoimmune disease (OR, 2.27; 95% CI = 1.21-4.28) and infections (OR, 2.13; 95% CI = 1.25-3.64). Familial WM patients were also more likely to report exposure to farming (OR, 2.70; 95% CI = 1.34-5.42), pesticides (OR, 2.83; 95% CI = 1.56-5.11), wood dust (OR, 2.86; 95% CI = 1.54-5.33), and organic solvents (multiple-case WM OR, 4.21; 95% CI = 1.69-10.51) compared with unaffected family members. These data provide clues to both genetic and environmental factors that may influence development of WM. Well-designed case-control studies are needed to confirm these findings.
Similar articles
-
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.J Natl Cancer Inst. 2010 Apr 21;102(8):557-67. doi: 10.1093/jnci/djq043. Epub 2010 Feb 24. J Natl Cancer Inst. 2010. PMID: 20181958 Free PMC article.
-
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.J Natl Cancer Inst Monogr. 2014 Aug;2014(48):87-97. doi: 10.1093/jncimonographs/lgu002. J Natl Cancer Inst Monogr. 2014. PMID: 25174029 Free PMC article.
-
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.Blood. 2008 Oct 15;112(8):3052-6. doi: 10.1182/blood-2008-06-162768. Epub 2008 Aug 13. Blood. 2008. PMID: 18703425 Free PMC article.
-
Familial Waldenström Macroglobulinemia: Families Informing Populations.Hematol Oncol Clin North Am. 2018 Oct;32(5):787-809. doi: 10.1016/j.hoc.2018.05.006. Epub 2018 Jul 26. Hematol Oncol Clin North Am. 2018. PMID: 30190018 Review.
-
Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.Acta Haematol. 2012;127(3):173-7. doi: 10.1159/000335618. Epub 2012 Feb 3. Acta Haematol. 2012. PMID: 22310551 Free PMC article. Review.
Cited by
-
Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.PLoS One. 2014 Jun 20;9(6):e100691. doi: 10.1371/journal.pone.0100691. eCollection 2014. PLoS One. 2014. PMID: 24950197 Free PMC article.
-
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):85-7. doi: 10.3816/CLML.2011.n.015. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21454199 Free PMC article. Review.
-
Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes.PLoS One. 2023 Jun 28;18(6):e0287602. doi: 10.1371/journal.pone.0287602. eCollection 2023. PLoS One. 2023. PMID: 37379307 Free PMC article.
-
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):194-7. doi: 10.1016/j.clml.2013.02.002. Epub 2013 Mar 7. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23473950 Free PMC article. Review.
-
Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan.Int J Hematol. 2017 Nov;106(5):681-690. doi: 10.1007/s12185-017-2297-y. Epub 2017 Jul 7. Int J Hematol. 2017. PMID: 28687991 Clinical Trial.
References
-
- Owen RG, Treon SP, Al Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30(2):110–115. - PubMed
-
- Berger F, Isaacson PG, Piris MA, et al. Lympho-plasmacytic lymphoma/Waldenström macroglobulinemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. pp. 132–134.
-
- Vijay A, Gertz MA. Waldenstrom macroglobulinemia. Blood. 2007;109(12):5096–5103. - PubMed
-
- American Cancer Society. Detailed guide: Waldenstrom macroglobulinemia. [Accessed December 22, 2009]. http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=76.
-
- Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003;102(10):3759–3764. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources